The immediate-early transactivator protein BICPO is a key regulatory element of bovine herpesvirus 1 (BHV-1) replication based on transient expression assays. To examine BICPO function in the context of the viral genome, we created recombinant BHV-1 expressing ß-galactosidase instead of BICPO. To complement the defect, a neomycin resistant MDBK cell line (M164) expressing BICPO was established, permitting selection of a blue-staining BHV-1 recombinant (A2G2). Southern blot and PCR analysis confirmed that the BICPO gene was interrupted by the ß-galactosidase gene and that wt progeny was absent. Compared with wt BHV-1, A2G2 reached lower titers in M164 cells but replicated with similar kinetics. Once isolated, A2G2 also grew in MDBK cells although the titer was reduced a further 10-fold and the virus remained strongly cell-associated. Thus, BICPO is not absolutely required for replication in cell culture. Gene expression of A2G2 was investigated by Western blots and immunofluorescence. Surprisingly, not only was BICPO absent, but glycoprotein C (gC) was also missing. Other viral genes were expressed normally. Semiquantitative PCR showed that A2G2 produced similar amounts of viral DMA as wt but a much smaller number of infectious particles. Cotransfection of A2G2 DNA and a plasmid containing the BICPO gene yielded revertant virus with fully restored wt properties. We conclude that BICPO is required for gC expression, and that the missing gC partly accounts for the reduced A2G2 infectivity.
Introduction
Herpesvirus infections are not restricted to humans. Many animals are hosts to specific herpesviruses which do not usually cross the species barrier. Bovine herpesvirus 1 (BHV-1) causes an economically important disease of cattle (forreviewsseeWylerefa/., 1989; Tikooefa/., 1995) . The disease is also known as infectious rhinotracheitis/pustular vulvovaginitis (IBR/IPV), a respiratory or genital infection, often accompanied by abortions or neurological symptoms. Like all herpesviruses, BHV-1 establishes latency in the infected host, from which it may be periodically reactivated during the host's lifetime (Ackermann ef a/., 1982; Ackermann and Wyler, 1984; Rock ef a/., 1992) . Latently infected ganglia are the main reason why eradication of this worldwide disease seems difficult to accomplish and has so far succeeded only in a few countries like Denmark and Switzerland.
During the lytic cycle of BHV-1 infection, viral genes are expressed in a cascade of three temporally distinct and functionally interdependent phases called immediateearly (IE), early, and late (Misra et a/., 1981; Wirth ef a/., 1989) . The IE phase can be induced by BHV-1 gene transinducing factor («TIF) supplied by the virion during acute infection (Misra ef a/., 1994; . Work from this laboratory has focused on the genes expressed during the IE phase (Figure 1 A, B) , which regulate the subsequent lytic cycle and may influence viral latency (Wirth etal., 1991; Fraefel ef a/., 1993; Schwyzer ef a/., 1993; Fraefel etal., 1994a, b) . The BHV-1 IE proteins have been characterized by rabbit antipeptide sera using Western blots, immunofluorescence and immunoadsorbent staining (Fraefel etal., 1994b; Koppel etal., 1995) . Transient expression assays revealed that BICPO, the BHV-1 homolog of herpes simplex virus type 1 (HSV-1) ICPO, may be a key element of the regulatory cascade (Wirth etal., 1992) ; it belongs to a novel class of proteins sharing a zinc finger motif designated RING finger (Barlow ef a/., 1994) . Using microinjection into Xenopus oocytes we showed that BICPO requires Zn 2+ for transactivation of viral promoters (Fraefel etal., 1994b) . The BICPO gene is located in the unique long (UL) region of the BHV-1 genome (Wirth ef a/., 1991; , close to the junction of U L with the inverted repeat (IR S ). A large part of the BICPO coding sequence, except the zinc finger homology, is overlapped in the opposite sense by the latency-associated transcripts (LAT) (Kutish and Rock, 1990) .
The purpose of the present study was to examine the functional role of the BICPO gene in the context of the viral genome. Using a transfer plasmid in which the BICPO co-ding sequence was interrupted by a beta-galactosidase (ß-gal) expression cassette, we generated recombinant BHV-1 expressing ß-gal in place of BICPO and compared its properties with those of wild type (wt) virus and of a revertant having a restored BICPO gene. The absence of BICPO led to strongly impaired but not completely abolished viral replication in Madin-Darby bovine kidney (MDBK) cells. An unexpected consequence of the missing BICPO was that no detectable amounts of glycoprotein C (gC) were produced in cells infected with the recombinant BHV-1, while other viral proteins were detected at normal levels. Semiquantitative PCR showed that the recombinant BHV-1, in comparison to wt BHV-1, produced similar amounts of viral DMA but a much smaller number of infectious particles. Furthermore, these particles remained strongly cell-associated.
Results

Selection of a BICPO Complementing Cell Line
Our goal was to examine the role of BICPO in viral replication by generating recombinant BHV-1 expressing ß-gal in the BICPO locus. Earlier studies had pointed to the importance of BICPO as a transactivator protein (Wirth et a/., 1992; Fraefel ef a/., 1994b) and suggested that recombinants lacking BICPO might not be viable. To facilitate propagation of such recombinants, we constructed a complementing MDBK cell line expressing the BICPO gene together with an antibiotic resistance gene as selective marker.
The BICPO gene was placed under the control of the CMV IE promoter, and LAT promoter sequences located downstream of the BICPO transcription termination site Figure. (A) The BHV-1 genome is a linear double-stranded DMA of 135 kb, subdivided into a unique long segment (U L ; 103 kb), a unique short segment (U s ; 10 kb), and inverted internal (IR S ) and terminal (TR S ) repeat sequences (11 kb each) flanking the U s segment. Map locations and orientations of the following genes are indicated: BHV-1 homologs of HSV-1 infected cell protein (BICP) 0,4,22, and 27; c/rc-encoded protein; glycoproteins B and C (gB, gC); latency-associated transcripts (LAT). (B) BICPO and BICP4 are encoded by alternatively spliced IE RNAs, IER2.9 and IER4.2, respectively An alternative promoter directs synthesis of ER2.6, an early viral RNA which also encodes BICPO (Wirth et a/., 1992) . (C) The plV1 OB transfer plasmid contains a 3.8 kb beta-galactosidase (ß-gal) expression cassette composed of the BHV-1 gB promoter, the ß-gal gene and the gB poly A signal (A n ) inserted into a single Sal I site which divides the BICPO open reading frame (ORF) into an amino-terminal (N-term.) and carboxy-terminal (C-term.) moiety. Positions of primers used in this study are indicated below the plasmid map. (D)The plasmid expressing BICPO (pBCMV26ALAT) contains the BICPO ORF from BstXI to Sspl under control of the human cytomegalovirus (CMV) IE promoter.
were removed to give pBCMV26ALAT ( Figure 1D ; Materials and Methods). The BICPO cassette was then inserted into the vector pgDNeo carrying a neomycin resistance gene. The resulting plasmid pgDNeoCMV26 was transfected using the calcium phosphate technique into MDBK cells which were kept under selective pressure with Geneticin. After three weeks, colonies of antibiotic-resistant cells appeared, and they were examined for expression of BICPO by immunofluorescence (not shown). In each cell population, only a small proportion of cells (a few percent) exhibited bright nuclear staining for BICPO; the remaining cells did not stain. After unsuccessful attempts to increase the proportion of BICPO-positive cells by subcloning, we picked cells from a single colony and designated them M164 cells. In a parallel experiment, we transfected MDBK cells with the original pgDNeo and selected a control cell line designated M165 which exhibits a BICPO-negative, antibiotic-resistant phenotype.
Construction of Recombinant BHV-1 Expressing ß-gal in Place of BICPO
When the experiments described here were started, M164 cells were not yet available. Thus, MDBK cells were cotransfected with wt (Cooper) viral DNA (Figure 1 A, B) and the plV10B transfer plasmid ( Figure 1C ). Virus progeny was harvested and screened for blue-staining recombinants. Approximately 20 blue plaques were picked, but they were difficult to purify and regularly produced mixed blue-and-white progeny in subsequent passages, possibly owing to a helper effect of residual wt virus. After the fourth passage on MDBK cells, two additional rounds of selection were performed by limiting dilution in 96-well microtiter plates on M164 cells to complement the BICPOdeficient virus and to separate it from wt contamination. After the second passage on M164 cells, no more whitestaining wt virus was observed in any of the wells. Recombinant virus from a single blue-staining well, designated A2G2, was selected for further analysis.
The A2G2 virus consistently produced blue-staining progeny in subsequent passages on M164 cells by limiting dilution or plaque assays, but final titers were 1 to 2 log units lower than those reached by wt virus. Furthermore, plaques formed more slowly with A2G2 than with wt virus (within 4 days instead of 2 days) although the final plaques could not be distinguished by their morphology.
Although the BICPO-positive cell line M164 had been instrumental in the selection of A2G2 virus, we found later that complementation was not absolutely required for virus propagation. Thus, a typical stock of A2G2 virus had a titer of 10 6 TCID 50 /ml as measured by limiting dilution assay on M164 cells; the same stock still exhibited a titer of 10 5 TCID 50 /nnl as measured on the BICPO-negative control cell line M165 or on the original MDBK cells. All wells showing signs of virus infection also exhibited blue staining and vice versa.
To help exclude the possibility that the observed properties of A2G2 virus were due to unplanned alterations elsewhere in the viral genome, we created a revertant of A2G2 virus as follows. MDBK cells were first transfected with a plasmid carrying a complete BICPO gene (pBCMV26) and then superinfected with A2G2 virus. White-staining revertant virus was expected to have a strong growth advantage over blue-staining A2G2 virus due to restoration of the BICPO gene. In fact, after two further passages of initially mixed progeny on MDBK cells, no blue-staining A2G2 remained detectable. Revertant virus from a single white-staining well was designated A2G2rev and characterized in parallel with A2G2 recombinant virus.
Genome Structure of A2G2 Recombinant Virus
The 3.8 kb ß-gal expression cassette inserted into the Sal I site of the BICPO gene contains a single EcoRI site just after the ß-gal coding sequence and a single Hind III site at the very end of the insert after the poly A signal ( Figure 1C ). These two sites should appear as additional cleavage sites in A2G2 DNA if the recombinant has been generated, as expected, by double crossover of plV10B flanking sequences with homologous sequences in the wt virus. Viral DNA was isolated from MDBK cells infected with A2G2, A2G2rev, or wt virus. Comparable yields were obtained in each preparation ( Furthermore, Southern blot hybridization using a ß-gal specific probe revealed a single 13 kb band for A2G2 DNA (Figure 3 , lane 3) and none for A2G2rev (lane 5) or wt DNA (lanel).
Hind III analysis: Because the U s part of the BHV-1 genome is invertible and contains Hind ill sites, the BICPO gene in wt DNA occurs in the half-molar Hind III fragments C and D (15.9 and 14.8 kb, respectively). After insertion of the 3.8 kb ß-gal cassette, both fragments should exhibit a net increase in size by 1.9 kb, the remainder being cleaved off at the additional Hind III site. Again, the Hind III restriction pattern of A2G2 DNA (Figure 2, lane 7) matched the prediction, since fragments C and D disappeared and were replaced by poorly resolved bands migrating just below fragment B (19.3 kb); A2G2rev (lane 8) exhibited the wt pattern (lane 6). Southern blot hybridization using a ß-gal specific probe revealed a band at 17 -18 kb for A2G2 DNA (Figure 3 , lane 4) and no signal for A2G2rev (lane 6) or wt DNA (lane 2).
To confirm the genome structure by other means and to assess the purity of the virus stocks, we performed PCR reactions as described in Materials and Methods. Primers o139 and o140 were used to generate an 897 bp product over the Sal I site of the undisrupted BICPO (Figure 1 C) . A band of the expected size was produced using template DNA from wt ( Figure 4 , lane 3) or A2G2rev (lane 2) virus stock. In contrast, DNA from A2G2 virus stock carrying the disruption in the Sal I site did not give rise to any of this 897 bp product (lane 4). Additional weaker bands appeared above and below the 897 bp band, but they were common to all three DNA preparations. In the converse experiment, primers o138 and o139 were used to produce a 1220 bp product over the Sal I site of the BICPO gene into the integrated ß-gal gene ( Figure 1C ). The 1220 bp product was only generated with A2G2 DNA (Figure 4 , lane 7), but not with wt virus DNA (lane 6).
Taken together, these experiments confirm that the A2G2 recombinant virus has the expected structure ( Figure 1 ) and that A2G2 virus stock is free of wt virus.
Gene Expression of A2G2 Recombinant Virus
Western blot analysis was performed to investigate how the absence of BICPO affected viral gene expression. MDBK cells were infected with wt virus, A2G2 recombinant, or A2G2rev virus. After 24 h, cells were lysed and proteins were separated electrophoretically. After blotting, the IE proteins BICPO, BICP4, BICP22, arc, and early protein BICP27 were revealed using rabbit antisera against synthetic peptides (Koppel ef a/., 1995); monoclonal antibodies were used for glycoproteins gC and gB (Friedli and Metzler, 1987) . The 97 kDa band of BICPO appeared only upon infection with wt virus ( Figure 5 ). As expected for a disrupted BICPO gene, in extracts of A2G2-infected cells no trace of the 97 kDa band could be detected. An unexpected finding was that the missing BICPO also led to the disappearance of gC; the corresponding 90 kDa band was only detected upon infection with wt and After 24 h, infected cells were lysed in gel sample buffer. Samples were loaded at 10 5 cell equivalents per slot, analyzed by SDS-polyacrylamide gel electrophoresis (8% acrylamide for BICP4, gB and gC; 10% acrylamide for all others), and electrophoretically transferred to nitrocellulose membranes. Proteins were then immunostained, either with rabbit antisera against synthetic peptides representing IE proteins BICPO, BICP4, BICP22, c/rc, and early protein BICP27 (Koppel ef a/., 1995) , or with monoclonal antibodies directed against glycoproteins gC and gB (Friedli and Metzler, 1987) . Positions and molecular mass of the virus-specific bands are indicated. Two different virus-specific bands are observed for BICP4 (Koppel etal., 1995) and gB (van Drunen Littel-van den Hurk and Babiuk, 1986 ).
A2G2rev but not at all with A2G2 recombinant virus. In contrast, gB was present both in wt virus-infected cells and in those infected by the A2G2 recombinant. Cleavage of gB (130 kDa) during infection (van Drunen Littel-van den Hurk and Babiuk, 1986) leads to a heterodimer (74 kDa and 55 kDa), of which only the larger moiety contains the epitope for the monoclonal antibody; this cleavage was more pronounced and the total amount of gB reduced in A2G2-infected cells. No major differences between cells infected with the three virus stocks were observed concerning IE proteins BICP4, BICP22, c/rc, and early protein BICP27 ( Figure 5 ).
The absence of BICPO and gC from A2G2-infected cells was also confirmed by immunofluorescence (not shown). Furthermore, CAT assays showed a clear activation of the gC promoter by BICPO, which reached a peak when 3 f mol of pBCMV26 were cotransfected with 160 f mol of gC-CAT (not shown).
Replication of A2G2 Recombinant Virus
In order to examine the contribution of the BICPO gene to replication of BHV-1 in cell culture, flasks of MDBK cells (25 cm 2 ) were infected with wt virus, A2G2 recombinant, or A2G2rev virus under the conditions of a single-burst experiment (m. o. i. = 5). At various times after infection, the culture medium (5 ml) was removed from the flasks, centrifuged, and supernatants were frozen at -20°C for later assay of virus in culture supernatant. Cell pellets were resuspended in 5 ml of fresh medium, added back to the cells remaining in the flasks and frozen at -20°C for later assay of cell-associated virus. At the end of the series, virus titers in culture supernatants were determined by limiting dilution assay on MDBK cells in microtiter plates. Cell-associated virus was released by three cycles of freezing-thawing before centrifugation and assay as above. As shown in Figure 6A , in cultures infected with wt or A2G2rev, cell-associated virus reached titers of 10 8 to . At various times the culture medium (5 ml) was removed from the flasks, centrifuged, and supernatants were frozen at -20 °C for later assay. Cell pellets were resuspended in 5 ml of fresh medium, added back to the cells remaining in the flasks and frozen at -20 °C for later assay. (A, C) At the end of the series, cell-associated virus was released into the medium by three cycles of freezing-thawing, separated from cell debris by centrifugation, and quantified by limiting dilution assay on MDBK cells in microtiter plates. (B, D) Titer of virus in supernatant was assayed in the same way except that the medium was just thawed and centrifuged without applying further freezing-thawing cycles.
10
9 TCID 50 /ml by 13 h p. i. and then leveled off at 10 7 to 10 8 TCIDso/ml. Recombinant A2G2 replicated to much lower titers of cell-associated virus (10 5 TCI D 50 /ml) but with similar kinetics (maximum titer at 16 h p. i.). Virtually all of the virus particles produced during A2G2 infection remained cell-associated. Titers of A2G2 virus in the culture supernatants ( Figure 6B) were rather low initially, and after 13 h p. i. they fell below the detection threshold. In contrast, infection with either wt or A2G2rev produced a steady increase of virus titer in the medium, until by 24 h p. i. larger amounts of virus were present in the culture supernatant ( Figure 6A ) than in the cellular compartment ( Figure 6B) .
In further experiments, infection was also carried out at m. o. i. = 0.01 to determine virus production over multiple rounds of infection. As shown in Figure 6C , there was a stepwise increase in cell-associated virus during 50 h of infection, and titers of about 10 8 TCID 50 /ml were reached for wt and A2G2rev virus. The titer reached by A2G2 recombinant virus was again about 3 log units lower. The overall kinetics was similar for all three viruses, except that the time to reach 100 % cytopathology was delayed for A2G2 (72 h versus 50 h). In this experiment, as shown in Figure 6D , more virus remained cell-associated than was released into the culture supernatant, especially for wt virus. However, unlike the result shown in Figure 6B , small amounts of A2G2 virus (10 4 TCID 5 o/ml) could be measured in the supernatant by 50 h ( Figure 6D ).
Ratio between Number of Viral Genomes and Infectious Particles
As mentioned above, viral DMA was isolated in similar yields from wt, A2G2 and A2G2rev although the corresponding virus stocks had rather different titers. To investigate whether this was due to differences in specific infectivity of the virus particles, we developed a semiquantitative PCR assay based on the addition of an internal control template. The region of the BHV-1 genome to be amplified using primers o1 and o2 consisted of 338 bp overlapping the 3' end of the BICPO gene ( Figure 1C) . From the resulting PCR product, an internal fragment of 51 bp was deleted. After religation of the outer fragments and agarose gel electrophoresis, a 287 bp fragment was isolated, quantified spectrophotometrically and added as tracer template to PCR reactions. Concentrations of BHV-1 DNA in the samples were estimated relative to the known fixed amount of tracer DNA by determining that point in a dilution series where 338 bp and 287 bp bands appeared with similar intensities.
Cultures of MDBK cells were infected at different m. o. i. (0.1 or1 or5)withwtorA2G2virus. After 48 h, virus in culture supernatant and cell-associated virus was harvested as above and combined. The number of infectious particles in each preparation was determined by limiting dilution assay. In parallel, a sample was removed from each preparation, diluted adequately, and the number of viral genomes was determined by semiquantitative PCR (Table  1) . Infection with wt virus produced 10 5 to 10 7 viral genomes per μΐ depending on m. o. i., whereas infection with A2G2 virus produced ten times smaller numbers. However, in accordance with the results shown in Figure 6 , the number of infectious particles produced by A2G2 infection was at least 3 log units lower than the corresponding number in wt infection. Consequently, the ratio between number of viral genomes and infectious particles ranged from 6 to 18 for wt infection and from 1800 to 18000 for infection by the A2G2 recombinant virus (Table 1) .
Discussion
In this report we showed that insertion of a ß-gal gene into the BICPO coding sequence produced a recombinant BHV-1 designated A2G2 which was able to replicate in cultured MDBK cells, albeit with severely reduced efficiency. Considering the importance of BICPO as a transregulator protein as observed earlier, we had anticipated an even more stringent impairment and had therefore prepared a BICPO-expressing cell line, designated M164, to complement the defect. As it turned out, in M164 cells the recombinant A2G2 virus reached only tenfold higher titers compared to M165 control cells or the MDBK parent cell line. The small percentage of M164 cells expressing BICPO may account for this low level of complementation and may itself be a consequence of intracellular toxicity of BICPO (N. Steinmann, R. Nunez, R. Koppel, and M. Ackermann, unpublished observation). Alternatively, expression of BICPO could depend on the cell cycle. As we now know, the plasmid used for stable transfection of the BICPO gene also encodes a product of the latency related gene which inhibits cell cycle progression (Schang et a/., 1996) .
Infection of MDBK cells with A2G2 carrying the interrupted BICPO gene produced no detectable BlCPO-specific bands in Western immunoblots. Rather unexpectedly, the missing BICPO also led to the complete disappearance of gC; the corresponding 90 kDa band was only detected upon infection with wt and A2G2rev but not at all with A2G2 recombinant virus. Since the gC gene itself was not changed in A2G2, the absence of gC expression had to be a consequence of the missing BICPO; this was supported by observations that BICPO activated the gC promoter in transient expression (CAT) assays. Synthesis of the other BHV-1 proteins examined remained largely unaffected in A2G2-infected cells. The observed reduction in synthesis of gB may have been caused by competition with the inserted ß-gal cassette which contains a BHV-1 gB promoter and polyadenylation site.
Thus, A2G2 may be expected to present a superposition of a BICPO-and gC-negative phenotype. Properties of gC-negative mutants alone have already been described. In cell culture they exhibit impaired attachment, delayed replication, and low titers of extracellular virus, whereas titers of cell-associated virus are similar to wt (Liang ef a/., 1991) . In experimental animals they are able to establish and maintain an infection (Liang ef a/., 1992) .
The BICPO-negative A2G2 described here resembles a gC-negative mutant in its preferential production of cellassociated virus. Unlike a regular gC-negative mutant, A2G2 is deficient with regard to final titers which are reduced by up to 3 log units. This effect can be specifically attributed to the absence of BICPO. Furthermore, the semiquantitative PCR described here showed that viral A2G2 DNA was synthesized in normal amounts, and that the impairment was due to the reduced specific infectivity of the virus particles.
Because of this impairment, it had initially proved difficult to separate the A2G2 recombinant virus from the pool of efficiently replicating wt virus. In contrast, transfection and reconstitution of the BICPO gene was easily accomplished, and a pure white-staining revertant of A2G2 was isolated in just two passages. With its characteristic staining and growth properties, A2G2 may serve as parent virus from which further recombinants with altered BHV-1 genes can be derived. For example, experiments are under way to insert a second gC gene under the control of a constitutive promoter into the BICPO locus.
Apart from reaching lower titers, the A2G2 recombinant exhibited a similar time course of virus production as wt or A2G2 revertant virus. Earlier experiments had shown strong stimulation of IE promoters by BICPO in transient expression assays. In the present work, when the role of BICPO was examined in the context of the viral genome, other IE proteins accumulated normally in A2G2-infected cells, and BICPO did not seem to be required for their synthesis. Furthermore, we observed that A2G2 DNA is infectious when cotransfected with a plasmid providing a-TIF (R. Koppel and B. Vogt, unpublished) . Thus, other viral proteins may substitute for the missing BICPO during induction of a lytic cycle.
Properties of the A2G2 recombinant resemble those of ICPO null mutants of HSV-1 (Cai and Schaffer, 1992; Chen and Silverstein, 1992) . Even though ICPO null mutants are viable and produce nearly wt levels of the other IE proteins, they are severely impaired with regard to early and late gene expression and, as a consequence, do not replicate efficiently. They have also been shown to be reactivated with a reduced frequency from mice infected via the ocular route; efficient transactivation by ICPO appears to be important for this process (Cai ef a/., 1993) . With the A2G2 recombinant, it will be possible to test the effect of a missing BICPO on BHV-1 reactivation in cattle, the natural host.
Materials and Methods
Cell Culture and Virus
MDBK cells were cultured in Eagle's minimal essential medium (EMEM; Gibco BRL, Basel, Switzerland) supplemented with 10% fetal bovine serum (FBS). BHV-1 strains Jura (Metzler ef a/., 1986) and Cooper (both of which belong to subtype 1) were propagated at a multiplicity of infection (m. o. i.) of 0.01 PFU in MDBK cells in EMEM containing 2% FBS.
Protein and DNA Analysis
Sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis and Western immunoblot (Fraefel et a/., 1994b) , indirect immunofluorescence (Fraefel ei a/., 1994a) , isolation of viral DNA (Wirth ef a/., 1989) , Southern blot analysis (Geng et a/., 1995) , and transient chloramphenicol acetyl transferase (CAT) expression assays (Wirth et a/., 1992) were carried out as described previously.
Construction of Plasmids
From pJuC (Wirth etal., 1991) , a 6.0 kb Hind Ill-Kpnl subfragment containing the entire BICPO gene and the 3' end of the BICP4 gene from BHV-1 strain Jura was cloned into a Hind lll-Kpnl-cut pUC19 vector. The resulting plasmid was opened at the unique Sal I site located in the BICPO gene, converted to blunt ends and used as a vector for insertion of the 3.8 kb -gal expression cassette composed of the BHV-1 gB promoter, the -gal gene and the gB poly A signal. The cassette was cut out from plasmid pEC4 (Mi Her eta/., 1995) with Hind III and Kpnl, converted to blunt ends and ligated into the vector. The resulting plasmid was designated plV1 OB ( Figure 1C ) and used as transfer plasmid for homologous recombination with BHV-1 strain Cooper genomic DMA.
The plasmid for stable expression of BICPO in MDBK cells was constructed as follows. From pBCMV26 (C. Fraefel, Y. Geng, S. LaBoissiere, C. Simard, M. Schwyzer, and M. Ackermann, in preparation), the LAT-promoter at the 3' end of the BICPO open reading frame (ORF) was removed by cutting with Ssp I and Xba I followed by blunt-end-ligation to give pBCMV26ALAT ( Figure  1D ). From this plasmid the EcoRI-Xhol fragment containing the BICPO gene under the control of the human cytomegalovirus (CMV) IE promoter was blunted and cloned into the Sal I site of pgDNeo (Okayama and Berg, 1983) to give the plasmid pgDNeoCMV26 used below.
Stable Transformation of MDBK Cells with the BICPO Gene
The transfer plasmid pgDNeoCMV26 (20 μg) wastransfected into a layer of 10 6 MDBK cells using the calcium phosphate technique (Gorman, 1985) . To produce a control cell line, the pgDNeo plasmid without BICPO expressing cassette was transfected in the same way. Selection was performed under 1 mg/ml Geneticin in DMEM. Three weeks later, clones became visible. Single clones were grown under 500 pg/ml Geneticin in DMEM and tested for expression of BICPO by indirect immunofluorescence. A BICPOpositive clone was selected and designated M164, and the corresponding BICP negative control cell line resistant to Geneticin was designated M165.
Construction of a BHV-1 Recombinant Carrying a -gal Gene in the BICPO Coding Sequence
MDBK cells were cotransfected with 8 μg BHV-1 strain Cooper DMA and 16 μg transfer plasmid (plV1 OB) using the calcium phosphate technique. Conditions for cotransfection, plating of progeny virus under agarose, and detection of recombinants by staining with Bluo-gal (Gibco) have been described previously (Fraefel etal., 1994a) . The first four rounds of selection of blue plaques were performed under agarose on MDBK cells. The picked plaques always produced additional white wt plaques in the next round of infection. Subsequently, two rounds of selection were performed by limiting dilution in96-well microtiter plates on M164 cells to complement the BICPO deficient virus with BICPO and to separate the recombinant virus from wt contamination. After testing blue-staining wells for absence of wt contaminants by PCR, a recombinant virus derived from a single well (designated A2G2) was selected and characterized further.
Construction of Revertant Virus
After transfection with pBCMV26 (see above), MDBK cells were superinfected with A2G2 recombinant virus. Several days later, supernatant was removed and virus was passaged twice on MDBK cells. A white staining revertant virus was isolated (designated A2G2rev) and characterized in parallel with A2G2 recombinant virus.
Qualitative PCR
Virus stock was boiled for 5 min, centrifuged 10 min at 20000 g, and 5 μΐ of the supernatant were used for PCR. Viral DMA (0.5 pg/pl) was diluted 1 :10000, and 5 μΐ were used for PCR. Primer pair for recognition of wt virus was o139 (5'CCTGCCCTTGCT-GCCGAACA) and o140 (5'GTCTAACTCTGTCCTTCTTCTCC) leading to an 897 bp product located within the BICPO gene. Primer pair for recognition of recombinant virus was o138 (5'AAACCAGGCAAAGCGCCATTCG) as -gal-specific primer and o139 leading to an expected 1.2 kb product. PCR was performed on a Perkin Elmer 480 Thermocycler as described except that Pfu DMA polymerase (Stratagene) was used in a step-down program (1 min at 95 °C; 1 min at 65 °C to 55 °C; 1 min at 72 °C), in which the annealing temperature was lowered from 65 °C to 55 °C in 1 °C decrements during the first 22 cycles and kept constant at 55 °C in the next 10 cycles. The reaction mix included 35 S-dATR and products were analyzed on a 5% polyacrylamide gel and revealed by autoradiography.
Semiquantitative PCR
Virus stock was treated as above, and the resulting supernatant was assayed for BHV-1 DMA in various dilutions. Primer pair o1 (S'CGCATGCGCGAGCAGTTACTTT) and o2 (5'CGAGAGCTCG-GCGCAGAAGA) was used to give a 338 bp product. These primers anneal to the 3' untranslated region and the C-terminal coding region of BICPO, respectively. To produce a template serving as internal control, a 51 bp fragment was excised with EcoO109! from the 338 bp product of a PCR reaction. After religation of the outer fragments and agarose gel electrophoresis, a 287 bp fragment was isolated, quantified spectrophotometrically and added as a tracer to the PCR reactions. PCR was performed as above, but on a different apparatus MJResearch) and with a different step-down program (1 min at 95 °C; 1 min at 60 °C to 57 °C; 1 min at 72 °C), in which the annealing temperature was lowered from 60 °C to 57 °C in 0.1 °C decrements during the first 31 cycles and kept constant at 57 °C in the next 10 cycles. The concentration of BHV-1 DMA in the samples was estimated relative to the known fixed amount of tracer DMA by determining that point in the dilution series where the 338 bp and 287 bp bands would appear with similar intensities.
